ROXAVVY

Serial Number 98011533
606

Registration Progress

Application Filed
May 24, 2023
Under Examination
Apr 16, 2024
Approved for Publication
Feb 1, 2024
Published for Opposition
Feb 20, 2024
Registered

Trademark Image

ROXAVVY

Basic Information

Serial Number
98011533
Filing Date
May 24, 2023
Published for Opposition
February 20, 2024
Abandonment Date
November 18, 2024
Drawing Code
3

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Nov 18, 2024
Classes
005

Rights Holder

BioMarin Pharmaceutical Inc.

03
Address
105 Digital Drive
Novato, CA 94949

Ownership History

BioMarin Pharmaceutical Inc.

Original Applicant
03
Novato, CA

BioMarin Pharmaceutical Inc.

Owner at Publication
03
Novato, CA

Legal Representation

Attorney
Richard M. LaBarge

Application History

19 events
Date Code Type Description
Nov 18, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Nov 18, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Apr 16, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 4, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 20, 2024 PUBO A PUBLISHED FOR OPPOSITION
Feb 1, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 1, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 31, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 14, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 5, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 5, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 5, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 19, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 19, 2023 GNRT F NON-FINAL ACTION E-MAILED
Dec 19, 2023 CNRT R NON-FINAL ACTION WRITTEN
Dec 19, 2023 DOCK D ASSIGNED TO EXAMINER
Jun 27, 2023 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED
Jun 26, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 27, 2023 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of genetic diseases and disorders

Additional Information

Design Mark
The mark consists of the word "ROXAVVY" in stylized red font to the right of a stylized double helix design that is colored in gradient shades beginning as blue at the top and transitioning to purple at the bottom.
Color Claim
The color(s) blue, purple, and red is/are claimed as a feature of the mark.

Classification

International Classes
005

USPTO Documents

Click to view cached USPTO documents for this trademark

Only administrators can request new documents from USPTO